NCT00548002View on ClinicalTrials.gov

Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

CompletedOBSERVATIONAL

Enrollment

430

Participants

Timeline

Start Date

January 31, 1999

Study Completion Date

August 31, 2002

Conditions

Staphylococcus AureusBacteremiaEndocarditisSepsis

Interventions

DRUG

trovafloxacin and levofloxacin

Trovafloxacin: \<60 kg 200 mg iv/orally once daily and \>60 kg 300 mg iv/orally once daily Levofloxacin: \< 60 kg 500 mg iv/orally once daily and \>60 kg 500 mg iv/orally bid

Trial Locations (1)

00029

Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki

All Listed Sponsors

lead

University of Helsinki

OTHER

NCT00548002 - Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia | Biotech Hunter | Biotech Hunter